Scilex Holding Company (SCLX) Financial Statements (2024 and earlier)
Company Profile
| Business Address |
960 SAN ANTONIO ROAD PALO ALTO, CA 94303 |
| State of Incorp. | DE |
| Fiscal Year End | December 31 |
| Industry (SIC) | 2836 - Biological Products, Except Diagnostic Substances (benchmarking) |
| More info | Complete Financial Analysis Financial Benchmarking |
Balance Sheet (Statement of Financial Position) ($ in thousands)
| 3/31/2024 MRQ | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | |||
|---|---|---|---|---|---|---|---|
| ASSETS | |||||||
| Current Assets | |||||||
| Cash, cash equivalents, and short-term investments | 3,921 | 2,184 | 304 | 31 | |||
| Cash and cash equivalents | 3,921 | 2,184 | 31 | ||||
| Short-term investments | 304 | ||||||
| Receivables | 3,200 | 21,236 | |||||
| Inventory, net of allowances, customer advances and progress billings | 4,214 | 1,378 | |||||
| Inventory | 4,214 | 1,378 | |||||
| Prepaid expense | 4,049 | 4,810 | 5 | ||||
| Deferred costs | 169 | ||||||
| Other undisclosed current assets | 31,397 | 204 | |||||
| Total current assets: | 46,781 | 29,608 | 512 | 199 | |||
| Noncurrent Assets | |||||||
| Operating lease, right-of-use asset | 2,943 | 1,131 | |||||
| Property, plant and equipment | 722 | 772 | |||||
| Intangible assets, net (including goodwill) | 49,966 | 54,072 | |||||
| Goodwill | 13,481 | 13,481 | |||||
| Intangible assets, net (excluding goodwill) | 36,485 | 40,591 | |||||
| Asset, held-in-trust | 139,411 | ||||||
| Deferred costs | 161 | ||||||
| Other undisclosed noncurrent assets | 897 | 944 | |||||
| Total noncurrent assets: | 54,528 | 56,919 | 139,411 | 161 | |||
| Other undisclosed assets | (161) | ||||||
| TOTAL ASSETS: | 101,309 | 86,527 | 139,923 | 199 | |||
| LIABILITIES AND EQUITY | |||||||
| Liabilities | |||||||
| Current Liabilities | |||||||
| Accounts payable and accrued liabilities, including: | 136,923 | 40,697 | 209 | 26 | |||
| Accounts payable | 40,954 | 8,450 | |||||
| Accrued liabilities | 95,969 | 32,247 | 26 | ||||
| Other undisclosed accounts payable and accrued liabilities | 209 | ||||||
| Debt | 108,429 | ||||||
| Due to related parties | ✕ | ✕ | 155 | ||||
| Other undisclosed current liabilities | 5,028 | 4,145 | |||||
| Total current liabilities: | 250,380 | 44,842 | 209 | 181 | |||
| Noncurrent Liabilities | |||||||
| Long-term debt and lease obligation | 17,038 | 483 | |||||
| Long-term debt, excluding current maturities | 17,038 | 483 | |||||
| Liabilities, other than long-term debt | 3,934 | 2,059 | 5,197 | ||||
| Deferred compensation liability, classified | 5,190 | ||||||
| Other liabilities | 179 | 163 | 7 | ||||
| Operating lease, liability | 2,237 | 665 | |||||
| Derivative instruments and hedges, liabilities | 1,518 | 1,231 | |||||
| Other undisclosed noncurrent liabilities | 2,895 | 3,387 | 3,352 | ||||
| Total noncurrent liabilities: | 23,867 | 5,446 | 9,032 | ||||
| Total liabilities: | 274,247 | 50,288 | 9,240 | 181 | |||
| Temporary equity, carrying amount | 139,380 | ||||||
| Equity | |||||||
| Equity, attributable to parent | (172,938) | 36,239 | (8,697) | 19 | |||
| Preferred stock | 3 | ||||||
| Common stock | 16 | 14 | 0 | 0 | |||
| Treasury stock, value | (90,522) | ||||||
| Additional paid in capital | 407,813 | 412,136 | 25 | ||||
| Accumulated deficit | (490,245) | (375,914) | (8,697) | (6) | |||
| Total equity: | (172,938) | 36,239 | (8,697) | 19 | |||
| TOTAL LIABILITIES AND EQUITY: | 101,309 | 86,527 | 139,923 | 199 | |||
Income Statement (P&L) ($ in thousands)
| 3/31/2024 TTM | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | ||
|---|---|---|---|---|---|---|
| Revenues | 46,743 | 38,034 | ||||
| Cost of revenue | (15,681) | (10,797) | ||||
| Gross profit: | 31,062 | 27,237 | ||||
| Operating expenses | (152,174) | (88,668) | (1,005) | |||
| Other undisclosed operating income | 15,681 | 10,797 | 2,599 | |||
| Operating loss: | (105,431) | (50,634) | (1,005) | |||
| Nonoperating income (expense) | (8,887) | 27,274 | ||||
| Other nonoperating expense | ||||||
| Interest and debt expense | (1,068) | 28,634 | (2) | |||
| Income (loss) from continuing operations before equity method investments, income taxes: | (115,386) | 5,274 | (1,007) | |||
| Other undisclosed income (loss) from continuing operations before income taxes | 1,068 | (28,634) | ||||
| Loss from continuing operations before income taxes: | (114,318) | (23,360) | (1,007) | |||
| Income tax expense | (13) | (4) | ||||
| Loss from continuing operations: | (114,331) | (23,364) | (1,007) | |||
| Loss before gain (loss) on sale of properties: | ✕ | ✕ | ✕ | (1,007) | ✕ | |
| Other undisclosed net income | 1,791 | |||||
| Net income (loss) attributable to parent: | (114,331) | (23,364) | 783 | |||
| Preferred stock dividends and other adjustments | (52,645) | (9,499) | ||||
| Net loss available to common stockholders, basic: | (166,976) | (23,364) | (8,716) | |||
| Dilutive securities, effect on basic earnings per share | 134,226 | |||||
| Other undisclosed net loss available to common stockholders, diluted | (134,226) | |||||
| Net loss available to common stockholders, diluted: | (166,976) | (23,364) | (8,716) | |||
Comprehensive Income ($ in thousands)
| 3/31/2024 TTM | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | ||
|---|---|---|---|---|---|---|
| Net income (loss): | (114,331) | (23,364) | 783 | |||
| Comprehensive income (loss), net of tax, attributable to parent: | (114,331) | (23,364) | 783 | |||
Statements Sources
The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.